| scholarly article | Q13442814 |
| P50 | author | Manuela Klingler-Hoffmann | Q37382658 |
| Peter Hoffmann | Q55382634 | ||
| Gurjeet Kaur | Q67248016 | ||
| P2093 | author name string | Chao Zhang | |
| Martin K Oehler | |||
| Georgia Arentz | |||
| Parul Mittal | |||
| P2860 | cites work | Between a chicken and a grape: estimating the number of human genes | Q21184037 |
| Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress | Q24310874 | ||
| Cancer biomarkers | Q26864429 | ||
| Emerging therapeutic biomarkers in endometrial cancer | Q26865904 | ||
| Mass spectrometry-based proteomics | Q28182890 | ||
| Mapping intact protein isoforms in discovery mode using top-down proteomics | Q28251805 | ||
| Mass spectrometry-based proteomics turns quantitative | Q28291379 | ||
| A model for random sampling and estimation of relative protein abundance in shotgun proteomics | Q29547316 | ||
| A molecular signature of metastasis in primary solid tumors | Q29614442 | ||
| Tryptic peptide reference data sets for MALDI imaging mass spectrometry on formalin-fixed ovarian cancer tissues. | Q30580264 | ||
| MALDI imaging mass spectrometry: molecular snapshots of biochemical systems | Q33300677 | ||
| Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells | Q33437632 | ||
| Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry | Q33532737 | ||
| Serum amyloid A: a novel biomarker for endometrial cancer | Q33643221 | ||
| Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis | Q33729850 | ||
| Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation | Q33860686 | ||
| Breast cancer proteomics: a review for clinicians | Q33862872 | ||
| Use of matrix-assisted laser desorption/ionisation mass spectrometry in cancer research. | Q33891886 | ||
| Analysis of expressed sequence tags indicates 35,000 human genes | Q33903985 | ||
| Revised FIGO staging for carcinoma of the endometrium | Q34016941 | ||
| Quantitation of spatially-localized proteins in tissue samples using MALDI-MRM imaging | Q34166763 | ||
| Serum proteomic profile analysis for endometrial carcinoma detection with MALDI-TOF MS | Q34174681 | ||
| The evolving role of mass spectrometry in cancer biomarker discovery | Q34215422 | ||
| Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer | Q34227653 | ||
| Detection of differential levels of proteins in the urine of patients with endometrial cancer: analysis using two-dimensional gel electrophoresis and o-glycan binding lectin | Q34403486 | ||
| MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays. | Q34574636 | ||
| Matrix-assisted laser desorption/ionization imaging protocol for in situ characterization of tryptic peptide identity and distribution in formalin-fixed tissue. | Q34589419 | ||
| Two pathogenetic types of endometrial carcinoma | Q34713298 | ||
| Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry | Q35134122 | ||
| Expression of matrix metalloproteinase-2 and survivin in endometrioid and nonendometrioid endometrial cancers and clinicopathologic significance | Q35154536 | ||
| The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities | Q35185640 | ||
| A new sample preparation method for the absolute quantitation of a target proteome using (18)O labeling combined with multiple reaction monitoring mass spectrometry. | Q35539755 | ||
| Integrating 'omic' information: a bridge between genomics and systems biology | Q35556187 | ||
| A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. | Q36006127 | ||
| Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum | Q36280125 | ||
| Molecular and pathologic aspects of endometrial carcinogenesis | Q36617660 | ||
| beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis | Q36622495 | ||
| Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus | Q36673983 | ||
| Novel molecular profiles of endometrial cancer-new light through old windows. | Q37025301 | ||
| Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma. | Q37200862 | ||
| Tissue culture-based breast cancer biomarker discovery platform | Q37246978 | ||
| Serum biomarkers for early detection of gynecologic cancers | Q37328423 | ||
| Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. | Q37337229 | ||
| Perspectives of targeted mass spectrometry for protein biomarker verification | Q37481709 | ||
| FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype | Q37486143 | ||
| Biologic markers in endometrial cancer treatment | Q37602229 | ||
| Proteomics and the search for biomarkers of female reproductive diseases. | Q37772364 | ||
| Label-free quantitative proteomics trends for protein-protein interactions | Q38059973 | ||
| State of the art of 2D DIGE. | Q38268593 | ||
| Large-scale proteomic characterization of melanoma expressed proteins reveals nestin and vimentin as biomarkers that can potentially distinguish melanoma subtypes | Q38947248 | ||
| Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence | Q38949774 | ||
| Comprehensive proteomic analysis of human endometrial fluid aspirate. | Q39956295 | ||
| Exploring the precursor ion exclusion feature of liquid chromatography-electrospray ionization quadrupole time-of-flight mass spectrometry for improving protein identification in shotgun proteome analysis | Q39982605 | ||
| Whole proteomes as internal standards in quantitative proteomics | Q41966883 | ||
| Implementation and evaluation of relative and absolute quantification in shotgun proteomics with label-free methods | Q42665323 | ||
| Monitoring of imatinib targeted delivery in human leukocytes. | Q43585487 | ||
| Serum HE4 as a prognostic marker in endometrial cancer--a population based study | Q43744083 | ||
| Co-expression of survivin, c-erbB2, and cyclooxygenase-2 (COX-2): prognostic value and survival of endometrial cancer patients. | Q43831889 | ||
| Abnormalities of the APC/beta-catenin pathway in endometrial cancer | Q45345268 | ||
| L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation. | Q45959051 | ||
| Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues | Q46481136 | ||
| High resolution two-dimensional electrophoresis of native proteins | Q50224443 | ||
| Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker. | Q50969109 | ||
| Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer. | Q51113485 | ||
| Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. | Q51456357 | ||
| Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis. | Q51807138 | ||
| A sensitive quantification of the peptide apidaecin 1 isoforms in single bee tissues using a weak cation exchange pre-separation and nanocapillary liquid chromatography coupled with mass spectrometry. | Q52783262 | ||
| The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer | Q57977987 | ||
| Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD | Q58316980 | ||
| P433 | issue | 3 | |
| P921 | main subject | endometrial cancer | Q944777 |
| cancer diagnosis | Q110324059 | ||
| P304 | page(s) | 217-229 | |
| P577 | publication date | 2015-12-15 | |
| P1433 | published in | Proteomics - Clinical Applications | Q15754475 |
| P1476 | title | Proteomics of endometrial cancer diagnosis, treatment, and prognosis | |
| P478 | volume | 10 |
| Q35984477 | Lymph node metastasis of primary endometrial cancers: Associated proteins revealed by MALDI imaging. |
| Q64249380 | MALDI-TOF-MS Analysis in the Identification of Urine Proteomic Patterns of Gestational Trophoblastic Disease |
| Q39438407 | Secreted tumor antigens - immune biomarkers for diagnosis and therapy. |
| Q64966051 | The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics". |
Search more.